Alpha Sense BI

MAY 5, 2023

After three volatile years, rife with challenging macroeconomic conditions — from a global pandemic and wars to far-reaching supply chain issues — the M&A space has its fair share of ups and downs. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. He joined Bell Labs in 1977 and held multiple leadership roles, including director of convergence strategy and global marketing.

Competitive 104

Competitive Competitive Intelligence Biotech Profiling 104

Fuld

NOVEMBER 1, 2022

“Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad. I plan to leverage that experience to help Fuld’s biotech and pharma clients successfully bring their own products to market. www.fuld.com.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

Wink Intel

MARCH 29, 2021

Canadian firm buys Ohio National for $1 billion; Net income of life/annuity industry fell almost 50% in 2020; New index annuity income rider from AIG; SIMON adds First Trust Target Outcome ETFs; KKR, owner of Global Atlantic, reports earnings; Voya, Morningstar in managed accounts partnership; A ‘longevity’ biotech SPAC. .

Biotech 40

Biotech Globalization Management 40

Alpha Sense BI

APRIL 29, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services—ushered in funding rounds over $100 million into 2024, providing optimism for a resurgence in deal activity. While VC deals on the whole are down and hovering near historic lows, there is still notable activity—even some megadeals.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

On the other hand, 2022 and 2023 brought mass layoffs , falling market capitalizations, and a weakening of global tech spending. In fact, projections for the global spatial computing market are valued at $269.8 In any case, this technology is one to watch—the global computing market is set to grow at a CAGR of 28.8%

Technology 69

Technology Technology Retail Due Diligence 69

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He received his Bachelor of Arts in Economics and Political Science from Williams College. Bryan Courtney- Bennett Sr.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

MARCH 13, 2024

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Wink Intel

FEBRUARY 23, 2021

We are excited to continue working with leading global financial institutions to further round out our fixed index annuity portfolio,” said American Equity Chief Executive Officer Anant Bhalla. tech and biotech ETFs and two fixed income components. Societe Generale is one of the largest European financial services groups.

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

Alpha Sense BI

MARCH 28, 2023

Value: To date, GLG serves leading technology, life science, and industrial companies, including 40% of the Fortune 100 and seven of the top 10 global technology companies; leading investment and financial firms; top professional services firms; and hundreds of nonprofits and social entrepreneurs around the world.

Value Chain 52

Value Chain Biotech Research Competitive 52

Evalueserve

DECEMBER 6, 2021

Global Healthcare Market – 2021. However, the emergence of a Delta variant of COVID-19 in Europe, the US, and China is fueling the need for ‘booster shots’ to sustain global recovery. According to the IMF, the global economy is likely to grow by 5.9% Global Healthcare M&A: Unprecedented Fightback 2.0.

Capital 98

Capital Globalization Marketing Marketing 98

Alpha Sense BI

JANUARY 25, 2023

Over the last three years, the COVID-19 pandemic brought new energy to manufacturing vaccines for a myriad of global diseases and health conditions. Moderna, BioTech, and Melanoma It started with what scientists considered to be impossible this past December. a potential cure for skin cancer. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Netbasequid

FEBRUARY 22, 2021

The global tech industry is projected to hit $5T in 2021 , which would represent a 4.2% Want to know how many biotech companies have received private funding over the last ten years? Search for biotech companies receiving private funding over the last ten years. From here, the biotech world is your oyster. With 6,415.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

JANUARY 26, 2024

We believe that this focus on accessibility and sustainability represents an alternative and attractive opportunity in supporting innovative solutions for global healthcare challenges. This renewed interest in rare disease therapeutics can be attributed to the U.S.

Biotech 59

Biotech Research Loss Algorithm 59

Sedulo

MARCH 15, 2023

Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

CIO

JANUARY 9, 2025

Las previsiones de las grandes consultoras, con una visin global del mercado, no siempre se corresponden con las tendencias que siguen las organizaciones, una vez se baja al detalle concreto. Jara, Chief Scientific Officer de Libelium; Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed; y Zigor Gaubeca, CIO de Grupo Aire.

Biotech 434

Biotech Globalization Learning IT 434

CIO

APRIL 3, 2025

At Biogen, she helped revolutionize the organizations digital capabilities in the highly regulated biotech industry. How did you approach strategic communications with those large, globally dispersed organizations you led? So once again, its providing clarity on, where are we going, whats acceptable to get there, and what isnt?

Biotech 468

Biotech IT Travel Win 468

CIO

NOVEMBER 25, 2024

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company.

Biotech 458

Biotech Matrix Learning Security 458

Alpha Sense BI

MARCH 14, 2025

While lingering concerns around tariffs and global policy pose macroeconomic uncertainty, experts widely agree that 2025 will mark a widespread return to IPO and deal activity , following years of low activity. If you are a GSK or a Pfizer or even an even smaller start-up biotech , exactly the same criteria is applied across.

Capital 59

Capital Biotech Startups Finance 59

Alpha Sense BI

FEBRUARY 6, 2025

In 2024, global M&A volume reached $3.4 North America led global M&A activity with 50% of deal volume, followed by EMEA at 25% and APAC at 22%. The tech sector accounted for 19% of global deal volume, followed by healthcare at 10% and finance at 9%. trillion seen in 2021. Novo Holdings Acquisition of Catalent: $16.5

Biotech 59

Biotech Capital Pharmaceutical Finance 59

Happy Market

MAY 9, 2022

John Dick: Right. [00:36:04].

Management 52

Management Entertainment Market Research Marketing Research 52

ATTEST

NOVEMBER 22, 2024

Boston’s innovation business ecosystem—from biotech startups in Kendall Square to fintech firms downtown—relies heavily on quality consumer insights. B2B International B2B International is a global market research firm specializing in B2B market research across various industries. Get your insights 2. Year Founded: 1998 3.

Market Research 52

Market Research Marketing Research Research Marketing 52

ATTEST

DECEMBER 20, 2024

From biotech startups in Torrey Pines to craft breweries in North Park, San Diego businesses rely on solid consumer insights to guide their decisions. The city has some well-establised traditional local agencies and modern research companies, each with their own expertise. Wherever you are, and whenever you need it.

Market Research 52

Market Research Marketing Research Research Marketing 52

Alpha Sense BI

NOVEMBER 9, 2022

billion), restructuring expense at ~$800 million (was $600 million) and global tax rate at ~23% (was 24%), while short-term incentive compensation expense is expected at ~$1.6 M&A IPOs to watch in Pharma and Biotech. Adjusted operating margin is expected to be strong as pricing should offset manufacturing costs in Q4. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

CIO

MARCH 4, 2025

Meanwhile, annual global investment in deep tech quadrupled from $15B to over $60B in 20162020 , signaling that investors see shorter paths to profit and indicating more technologies funded five or more years ago have now reached commercial readiness. It was hard to imagine this pace 5-10 years ago.

Technology 442

Technology Technology Biotech Business 442

Alpha Sense BI

APRIL 3, 2025

Concurrently, smaller biotech firms and midsized companies offering promising innovations, particularly in high-demand therapeutic areas such as oncology, immunology, neuroscience, and cardio-metabolic conditions, are expected to become highly attractive targets. How will tariff policies play out?

Biotech 59

Biotech Pharmaceutical Loss Research 59

Alpha Sense BI

JANUARY 8, 2025

RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement.

Innovation 69

Innovation Biotech Pharmaceutical Benchmarking 69